, India

What investment opportunities await for India’s health-tech space?

Before the pandemic, the industry focussed on wearables, lifestyle-linked problems, and more.

New opportunities are likely to emerge in India’s health-tech space after the pandemic, including the development of tools for facilitating emergency care and improvements to medical infrastructure through tech-based  optimisation, according to a report from NITI Aayog.

For example, the scope of wearable devices could be expanded to track health conditions. “Patient-facing mobile health applications could also be developed, along with enabling greater integration of AI, robots, and blockchain technologies e.g., surgical robots, sensors, remote diagnostics, electronic records and monitoring systems,” the report stated.

Amidst a shortage of doctors, AI doctors could also offer a long-term solution, especially in rural and remote areas.  A  leading NATHEALTH provider engaged with a state  government in a PPP project covering 182 Electronic Urban Primary Healthcare centres (E-UPHCs).

With a daily footfall of 12,000, the program has touched 5.2 million lives over two years. “This model can be replicated in other rural areas with private players. E-lCUs can also be set up in semi-urban and rural areas, and connected to a central monitoring hub,” the report added.

Before the pandemic, the health-tech industry was primarily focussed on developing wearable gadgets, diagnostics and medicine delivery solutions; facilitating early diagnosis of genetic conditions; treating lifestyle-linked problems like stress and anxiety through remote therapy as well as post-procedure pain alleviation.

A low presence of doctors in semi-urban, rural and remote areas has resulted in limited access to healthcare facilities for large numbers of people. Telemedicine and e-health are considered to  be potential solutions for addressing this lack of access, given the extensive smartphone penetration in India and improving mobile connectivity.

“Tele-radiology is also an emerging area with several foreign hospitals now active in this space. These hospitals consult Indian experts for providing opinions to patients,” the report stated.

Many hospitals have adopted the PPP route to render services through telemedicine, especially during the pandemic, the report added. A developed telemedicine market could also offer potential for future export of healthcare services.

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.